IMR Press / RCM / Volume 24 / Issue 4 / DOI: 10.31083/j.rcm2404121
Open Access Review
Alcohol and Cardiovascular Disease: Helpful or Hurtful
Show Less
1 Department of Medicine, St Mary Medical Center, Langhorne, PA 19047, USA
2 Department of Cardiology, St Mary Medical Center, Langhorne, PA 19047, USA
*Correspondence: vincent.figueredo@stmaryhealthcare.org (Vincent M. Figueredo)
Rev. Cardiovasc. Med. 2023, 24(4), 121; https://doi.org/10.31083/j.rcm2404121
Submitted: 1 December 2022 | Revised: 17 February 2023 | Accepted: 16 March 2023 | Published: 19 April 2023
(This article belongs to the Section Heart Diseases)
Copyright: © 2023 The Author(s). Published by IMR Press.

This is an open access article under the CC BY 4.0 license.

Abstract

Alcohol has been considered throughout history as both a tonic and a poison. The answer as to which likely depends on one’s current health, the amount one consumes, and with what regularity. In examining the relationship of alcohol and cardiovascular health, most, but not all, epidemiological studies suggest that light to moderate alcohol consumption can reduce the incidence of coronary artery disease (CAD), ischemic stroke, and peripheral arterial disease events. Conversely, abuse of alcohol can lead to cardiomyopathy, heart failure, sudden death, and hemorrhagic strokes. In this article, we review the literature studying the effects of alcohol on coronary artery disease and stroke. A recently published study concluded there was no amount of alcohol per day that was heart healthy. Yet more than one hundred previous studies have found that people who drink in moderation have a lower risk of cardiovascular disease events when compared to those who do not drink or drink heavily. Moderate drinking is defined as one to two drinks per day; where one drink is defined as 12 ounces of beer, 5 ounces of wine or 1.5 ounces of hard liquor. In this article we reviewed the data suggesting that consuming alcohol in moderation on a regular basis–as opposed to 7 drinks on Saturday night–could have cardiovascular protective effects.

Keywords
cardiovascular
vascular function
alcohol abuse
stroke
cardiomyopathy
1. Introduction

Alcohol has been considered throughout history as both a tonic and a poison. The answer as to which likely depends on one’s current health, the amount one consumes, and with what regularity. In examining the relationship of alcohol and cardiovascular health, most, but not all, epidemiological studies suggest that light to moderate alcohol consumption can reduce the incidence of coronary artery disease (CAD), ischemic stroke, and peripheral arterial disease events. Conversely, abuse of alcohol can lead to cardiomyopathy, heart failure, sudden death, and hemorrhagic strokes. In this article, we reviewed the recent literature on PubMed to update past reviews of the association between alcohol and cardiovascular disease.

A recent study concluded there was no amount of alcohol per day that was heart healthy [1]. Yet more than one hundred previous studies have found that people who drink in moderation have a lower risk of cardiovascular disease events when compared to those who do not drink or drink heavily [2, 3, 4, 5, 6, 7, 8, 9, 10]. Moderate drinking is defined as one to two drinks per day; where one drink is defined as 12 ounces of beer, 5 ounces of wine or 1.5 ounces of hard liquor [4]. In this article we reviewed the data suggesting that consuming alcohol in moderation on a regular basis–as opposed to 7 drinks on Saturday night–may be associated with cardiovascular protective effects.

2. Alcohol and Coronary Artery Disease

Coronary artery disease (CAD) is one of the most significant health burdens in modern societies. CAD causes higher numbers of death and loss of Disability Adjusted Life Years (DALYs) compared to all other diseases [2]. The number of deaths due to CAD has increased by 50% since the 1990s. CAD is the leading cause of death in the United States, and the third leading cause around the world [3]. Significant consumption of alcohol has been shown to be associated with development of CAD [4]. Conversely, some studies have found cardiovascular beneficial effects of alcohol in moderation [4].

The role of alcohol in CAD has been argued for decades by experts and researchers. The amount of alcohol consumed has been shown to be a major factor determining the potential beneficial or harmful effects for CAD; a similar phenomenon being observed in the relationship of alcohol to other cardiovascular diseases [4]. In 1986, Moore and Pearson, reviewed cross-sectional, cohort, and epidemiological studies across various populations examining the relationship between moderate alcohol consumption and CAD, and concluded that there is an inverse relationship between moderate alcohol use and CAD development. The findings were attributable to the beneficial effects of moderate use of alcohol on high-density lipoprotein (HDL) and apoliporoteins [5]. Similarly, another more recent review came to a similar conclusion citing more evidence [6]. Furthermore, the association of moderate alcohol use and lower risk of CAD has been strengthened by findings in a number of meta-analyses over the past decade. Costanzo et al. [7], in their meta-analysis found 30% more protection against vascular risk, including CAD, in patients who consumed 20 g of alcohol per day. Similarly, Zhang et al. [8] pooled data from 35 studies comparing moderate drinkers with non-drinkers and found a reduced risk of CAD in moderate drinkers, with an odds ratio (OR) of 0.68. Yet another meta-analysis, involving nearly 100,000 participants and 39,000 ischemic heart disease events, also found a cardioprotective association with low to moderate alcohol use for ischemic heart disease [9]. Song and colleagues, in a study on US veterans found that low to moderate alcohol consumption reduced the risk of CAD in veterans [10]. Regardless of population studied, sex, or type of alcohol consumed in regular moderation, the relationship between alcohol intake and ischemic heart disease demonstrated a J-shaped relationship [2, 3, 4, 5, 6, 7, 8, 9, 10]. Low to moderate alcohol consumption appeared to have a protective effect against coronary artery disease events when compared to heavy alcohol consumption or abstention.

Some have argued that the inverse association between moderate alcohol consumption and CHD may be partially attributed to a poorly defined reference group. For example, the reference group of non-drinkers could include heavy drinkers who deny alcohol intake or who have stopped drinking alcohol due to illness. More recent studies are better at excluding individuals who abstain for health reasons and have found a similar reduction in risk, suggesting that the reduction is not attributed to this potential bias.

In contrast to the aforementioned studies and meta-analyses, Biddinger et al. [1] recently concluded there was no amount of alcohol per day that was healthy. However, when reviewing the data from the study, we and others [11] find that light alcohol intake (3–6 drinks per week) shows cardiovascular benefits.

In contrast to the beneficial effects of moderate use, excess alcohol consumption has been found to be harmful, increasing the risk for CAD [12, 13, 14]. Studies have suggested that light to moderate drinkers who also partake in episodic binge drinking, have increased risk of CAD [13, 15]. In contrast to numerous studies finding that binging has no cardioprotective effect, and possibly a negative one, a recent study by Degerud et al. [16] did not find a significant association between binge drinking and ischemic heart disease. Table 1 (Ref. [16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39]) shows study characteristics for studies included in the above reviews and meta-analyses examining moderate alcohol use and coronary artery disease.

Table 1.Study Characteristics for Studies Included in Reviews and Meta-Analyses Reported on Examining Moderate Alcohol Use and Coronary Artery Disease.
Study Study design Country Number of participants % Men and women Average age (years) Alcohol consumption HR/OR/RR (95% Confidence Interval)
Yusuf et al., 2004 [17] Case Control 52 countries (North America, Asia, Europe, Middle East, Africa) 15,463 80.6% Men 61.5 3 or more drinks/week OR: 0.91 (0.82–1.02)
19.4% Women
Hvidtfeldt et al., 2010 [18] Prospective North America, Europe 23,733 47.9% Men 52.5 15–29.9 g/day HR: Men 0.72 (0.64–0.82)
52.1% Women Women 0.52 (0.40–0.67)
Mukamal et al., 2006 [19] Prospective United States of America 8867 100% Men 56.0 15–29.9 g/day HR: 0.38 (0.16–0.89)
Ikehara et al., 2013 [20] Prospective Japan 47,100 100% Women 49.3 20–45 g/day HR: 0.84 (0.36–1.97)
Arriola et al., 2009 [21] Prospective Spain 41,438 37.8% Men 49.0 5–30 g/day HR: Men 0.49 (0.32–0.75)
62.2% Women Woman 0.62 (0.36–1.07)
Tolstrup et al., 2006 [22] Prospective cohort Denmark 53,500 46.7% Men 50–65 years 24–48 g/week HR: Men 0.78 (0.66–0.94)
53.3% Women Women 0.63 (0.52–0.77)
Britton and Marmot, 2004 [23] Prospective cohort United Kingdom 10,308 100% Men 35–55 years 10–80 g/week HR: Men 0.99 (0.78–1.25)
Women 0.96 (0.67–1.38)
Athyros et al., 2007 [24] Cross-Sectional Greece 4153 49.0% Men 47.4 20–45 g/day OR: Men 0.62 (0.49–0.82)
51.0% Women Women 0.57 (0.32–0.76)
Tanasescu et al., 2001 [25] Prospective United States of America 2419 100% Men 60.1 0.5–2 drinks/day (7–28 g/day) RR: 0.64 (0.40–1.02)
Kitamura et al., 1998 [26] Prospective Japan 8476 100% Men 40–59 years 23–45 g/day RR: 0.55 (0.29–1.05)
Rimm et al., 1991 [27] Prospective United States of America 44,059 100% Men 53.1 15–30 g/day RR: 0.73 (0.51–1.05)
Solomon et al., 2000 [28] Prospective cohort United States of America 5103 100% Women 48.1 0.1–4.9 g/day RR: 0.45 (0.29–0.68)
Mukamal et al., 2003 [29] Prospective United States of America 5882 100% Men 53.6 15–29.9 g/day RR: 0.79 (0.64–0.96)
Beulens et al., 2007 [30] Prospective cohort United States of America 11,711 100% Men 60.0 15–29.9 g/day HR: 0.72 (0.54–0.97)
Bos et al., 2010 [31] Prospective cohort Europe 17,357 100% Women 54.0 30–69.9 g/day HR: 0.92 (0.68–1.24)
Fernandez-Jarne et al., 2003 [32] Case control Spain 171 96% Men 59.5 20–29.9 g/day OR: 0.41 (0.12–1.34)
4% Women
Fuchs, 2004 [33] Prospective cohort United States of America 14,506 33.2% White Men 45–64 years 140–210 g/week for Men HR: White men 0.81 (0.45–1.44)
39.9% White Women 1–70 g/week for Women White women 0.64 (0.36–1.12)
10.0% Black Men Black men 2.67 (1.12–6.34)
16.8%Black Women Black women 0.49 (0.20–1.18)
Degerud et al., 2021 [16] Cross-sectional Norway 44,476 70.7% Men 49.7 12–23.99 g/day HR: 0.82 (0.58–1.17)
29.9% Women
Ebbert et al., 2005 [34] Prospective cohort United States of America 30,518 100% Women 61.3 1–14 g/day HR: 0.77 (0.61–0.97)
Murray et al., 2002 [35] Prospective cohort Canada 1154 50.3% Men 42.0 5.78–18.1 g/day for Men HR: Men 0.70 (0.26–1.85)
49.7% Women 2.93–9.15 g/day for Women Women 0.96 (0.67–1.38)
Song et al., 2017 [36] Observational cohort United States of America 156,728 95% Men 67.3 12–24 g/day HR: 0.79 (0.61–0.81)
5% Women
Mukamal et al., 2006 [37] Prospective United States of America 4410 54.8% Men 72.4 7–13 drinks/week (84–156 g/week) RR: 0.71 (0.50–1.01)
45.2% Women
Ikehara et al., 2009.[38] Prospective Japan 19,356 100% Men 53.1 150–299 g/week HR: 0.23 (0.12–0.37)
Marques-Vidal et al., 2004 [39] Prospective France, Ireland 7352 100% Men 54.8 7–14 drinks/week (84–168 g/week) RR: 0.65 (0.39–1.08)
OR, odds ratio; HR, hazard ratio; RR, relative risk.

An often-heard criticism of this theory of alcohol-mediated cardioprotection is that investigators receive funding or are influenced by the alcohol industry to find this “positive” association. While early studies may have been unduly influenced, investigators are becoming increasingly aware of the issues related to conflict of interest. We reviewed the funding sources for all studies referenced. All were funded by their country or university, with a majority funded by the US National Institutes of Health (NIH). Only one study [5] was funded by the Alcoholic Beverage Research Foundation, as well as the NIH. Furthermore, there are multiple plausible mechanisms of alcohol’s cardioprotective effect that have been demonstrated.

3. Possible Mechanism(s) of Alcohol’s Cardioprotective Effect

The exact mechanism(s) of the beneficial effects of moderate drinking on CAD are not completely understood, but several hypotheses have been put forward. Alcohol favorably effects cardiovascular biomarkers, which in turn decreases risk of CAD. For example, moderate consumption increases HDL cholesterol and adiponectin, and decreases fibrinogen [40]. Alcohol can also indirectly lower risk of CAD by affecting risk factors. For example, studies have shown that low to moderate alcohol use positively affects insulin sensitivity, protecting against diabetes, and in turn CAD [41].

Alcohol can affect the constriction and relaxation of blood vessels. Studies have reported that heavy ethanol hinders the nitric-oxide generating system of endothelium [42]. In contrast, low to intermediate ethanol improves the endothelial function by increasing the expression of nitric oxide synthases. For example, Liu et al. [43] found that low ethanol improved endothelial nitric oxide synthase (eNOS) expression in endothelial cells in vitro. Similar results were reported by Kleinhenz et al. [44]. On the other hand, higher amounts of ethanol disrupted the endothelial function by reducing the production of eNOS [45]. In a case control study, researchers found that heavy alcohol consumers had impaired endothelial vasodilation compared to normal subjects [46]. Binge alcohol drinking also disrupts endothelial function as shown by Hijmering et al. [47]. They found that binge alcohol consumption caused endothelial dysfunction by decreasing flow mediated vasodilation. Another study found that previous heavy alcoholics, even after abstinence, had persistent endothelial dysfunction [48].

A study by Whitfield et al. [49] reported that HDL cholesterol increases as alcohol amount is increased, while there is an inverse relationship with insulin levels. There was a J-shaped relationship between the amount of alcohol consumed and triglycerides levels. Xiao et al. [50], in a cross-sectional study involving 20,502 participants, reported increases in HDL cholesterol and decreasing triglycerides associated with alcohol consumption. In another study, Budzyński and colleagues [51] studying the effect of alcohol abstinence on plasma lipid levels, found a statistically significant increase in plasma low-density lipoprotein (LDL) and decrease in HDL and lipoprotein after 4 weeks of alcohol discontinuation. A cross-sectional study involving 4850 participants aged 65 years and older investigated the effect of alcohol on lipoprotein sub particles. They found that use of alcohol was associated with low levels of total LDL, small LDL, very-low-density lipoprotein (VLDL), and small HDL particles while there was increase in large and medium HDL particles [52]. These effects of alcohol were also supported by studies using Mendelian Randomization approach. For example, Tabara et al. [53], reported increased HDL and decreased LDL and triglycerides with the use of alcohol.

4. Alcohol and Cerebrovascular Disease

According to the data from the World Stroke Organization, 13 million individuals suffer a stroke each year. Sixty percent of these cases occur in individuals under age 70, and 8% of these occur in individuals under age 44. Stroke is the third leading cause for death and disability worldwide [54]. Alcohol use is considered as an important risk factor for stroke.

According to the data from the World Stroke Organization, 66% of strokes are attributable to behavioral and lifestyle factors. Alcohol use contributed to 11% of that burden [54]. Many studies in the past have reported a positive link between heavy alcohol use and cerebrovascular disease. Klatsky et al. [55] found that heavy drinking was associated with increased risk of hemorrhagic stroke. Other studies have found a relationship of alcohol use with the development of aneurysmal subarachnoid hemorrhage [56, 57] and hemorrhagic stroke [58, 59]. In contrast, studies have also found that alcohol consumption in moderate quantities can provide a protective effect [60].

A study conducted by Jimenez at all reported a U-shaped relationship between the use of alcohol and risk of stroke in women [61]. A Japanese study, investigating the association of light to moderate alcohol and risk of stroke, involving 19,550 individuals with follow up of 10 years, found that light to moderate use does not increase the risk of stroke [62]. A recent meta-analysis published in 2016, including articles from 1966–2016, sought to determine the association of alcohol consumption with different stroke types. The analysis showed that low to moderate consumption was associated with lower risk of stroke development and higher consumption was associated with higher risk of stroke. More specifically, light and moderate alcohol consumption was shown to reduce the risk of ischemic stroke, but not hemorrhagic stroke, whereas heavy use increased the risk of both ischemic and hemorrhagic stroke [63]. Another meta-analysis, investigating the relationship between alcohol use and morbidity and mortality due to various types of strokes, reported that light to moderate consumption may be protective, while excessive use increases the risk of stroke. They found a J-shaped association between alcohol use and different types of strokes [64]. A recent study Zhang and colleagues reported a J-shaped association with alcohol use and stroke in the Chinese population. A lower quantity of alcohol (1–150 g/wk) reduced the risk, while excessive intake (>350 g/wk) increased the risk of stroke [65]. In contrast, another larger prospective study involving 512,715 Chinese adults and followed for ten years did not find a protective effect of alcohol for stroke. Instead they found a positive log-linear association of stroke risk with alcohol consumption [66].

5. Conclusions

Current guidelines, and most physicians today, will recommend to their patients limiting alcohol intake to one drink per day for women, and two drinks per day for men. Favorable biological effects include anti-inflammatory, antioxidant, and hemorheological effects, as well as modulation of cardiovascular risk factors. Epidemiological data suggest that alcohol in moderation is associated with cardiovascular protective effects. While laboratory studies on the effects of alcohol on cardiovascular disease risk factors suggest mechanisms of alcohol-mediated cardioprotection, clinical studies to date can only suggest clinical benefit and are hypothesis generating. Randomized control trials will be required to further clarify whether such protection is clinically found.

Due to the lack of randomized control trials, routine recommendations to initiate alcohol consumption for cardioprotection should not be made, especially given its potential for addiction and abuse. Nevertheless, from our review of the current literature there is no significant justification to encourage abstinence in light to moderate drinkers.

We reviewed the funding sources from the studies reported in this review and saw little funding from the alcohol industry. However, we cannot know whether funding sources from the alcohol industry may have not been listed by all authors. The question of industry influence must be acknowledged and has been studied [67, 68, 69].

Most will agree that if you are physically active, do not smoke, eat a healthy diet, are not overweight, and have no family history of heart disease, there is little added benefit from drinking alcohol to protect your heart. However, in patients at risk for cardiovascular events who already responsibly consume alcohol, there is little reason to encourage abstinence.

Author Contributions

AP and VF reviewed the literature and prepared the manuscript. AP and VF contributed to editorial changes in the manuscript. All authors read and approved the final manuscript. All authors have participated sufficiently in the work and agreed to be accountable for all aspects of the work.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This research received no external funding.

Conflict of Interest

The authors declare no conflict of interest. Vincent M. Figueredo is serving as one of the Editorial Board members and Guest Editors of this journal. We declare that Vincent M. Figueredo had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Ezra Abraham Amsterdam and Giuseppe Boriani.

References
[1]
Biddinger KJ, Emdin CA, Haas ME, Wang M, Hindy G, Ellinor PT, et al. Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease. JAMA Network Open. 2022; 5: e223849.
[2]
Ralapanawa U, Sivakanesan R. Epidemiology and the Magnitude of Coronary Artery Disease and Acute Coronary Syndrome: A Narrative Review. Journal of Epidemiology and Global Health. 2021; 11: 169–177.
[3]
Brown JC, Gerhardt TE, Kwon E. Risk Factors For Coronary Artery Disease. StatPearls Publishing: Treasure Island (FL). 2022.
[4]
O’Keefe JH, Bhatti SK, Bajwa A, DiNicolantonio JJ, Lavie CJ. Alcohol and cardiovascular health: the dose makes the poison…or the remedy. Mayo Clinic Proceedings. 2014; 89: 382–393.
[5]
Moore RD, Pearson TA. Moderate alcohol consumption and coronary artery disease. A review. Medicine. 1986; 65: 242–267.
[6]
Hines LM, Rimm EB. Moderate alcohol consumption and coronary heart disease: a review. Postgraduate Medical Journal. 2001; 77: 747–752.
[7]
Costanzo S, Di Castelnuovo A, Donati MB, Iacoviello L, de Gaetano G. Wine, beer or spirit drinking in relation to fatal and non-fatal cardiovascular events: a meta-analysis. European Journal of Epidemiology. 2011; 26: 833–850.
[8]
Zhang XY, Shu L, Si CJ, Yu XL, Liao D, Gao W, et al. Dietary Patterns, Alcohol Consumption and Risk of Coronary Heart Disease in Adults: A Meta-Analysis. Nutrients. 2015; 7: 6582–6605.
[9]
Roerecke M, Rehm J. The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction. 2012; 107: 1246–1260.
[10]
Song RJ, Nguyen XMT, Quaden R, Ho YL, Justice AC, Gagnon DR, et al. Alcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program). The American Journal of Cardiology. 2018; 121: 1162–1168.
[11]
Komaroff AL. Harvard Health Letter. 2022; 47: 2.
[12]
Ruidavets JB, Ducimetière P, Evans A, Montaye M, Haas B, Bingham A, et al. Patterns of alcohol consumption and ischaemic heart disease in culturally divergent countries: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). British Medical Journal. 2010; 341: c6077.
[13]
Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Medicine. 2014; 12: 182.
[14]
Klatsky AL. Alcohol and cardiovascular diseases: where do we stand today? Journal of Internal Medicine. 2015; 278: 238–250.
[15]
Roerecke M, Rehm J. Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. American Journal of Epidemiology. 2010; 171: 633–644.
[16]
Degerud E, Høiseth G, Mørland J, Ariansen I, Graff-Iversen S, Ystrom E, et al. Associations of Binge Drinking With the Risks of Ischemic Heart Disease and Stroke: A Study of Pooled Norwegian Health Surveys. American Journal of Epidemiology. 2021; 190: 1592–1603.
[17]
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. ACC Current Journal Review. 2004; 13: 15–16.
[18]
Hvidtfeldt UA, Tolstrup JS, Jakobsen MU, Heitmann BL, Grønbaek M, O’Reilly E, et al. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation. 2010; 121: 1589–1597.
[19]
Mukamal KJ, Chiuve SE, Rimm EB. Alcohol consumption and risk for coronary heart disease in men with healthy lifestyles. Archives of Internal Medicine. 2006; 166: 2145–2150.
[20]
Ikehara S, Iso H, Yamagishi K, Kokubo Y, Saito I, Yatsuya H, et al. Alcohol consumption and risk of stroke and coronary heart disease among Japanese women: the Japan Public Health Center-based prospective study. Preventive Medicine. 2013; 57: 505–510.
[21]
Arriola L, Martinez-Camblor P, Larrañaga N, Basterretxea M, Amiano P, Moreno-Iribas C, et al. Alcohol intake and the risk of coronary heart disease in the Spanish EPIC cohort study. Heart. 2010; 96: 124–130.
[22]
Tolstrup J, Jensen MK, Tjønneland A, Overvad K, Mukamal KJ, Grønbaek M. Prospective study of alcohol drinking patterns and coronary heart disease in women and men. British Medical Journal. 2006; 332: 1244–1248.
[23]
Britton A, Marmot M. Different measures of alcohol consumption and risk of coronary heart disease and all-cause mortality: 11-year follow-up of the Whitehall II Cohort Study. Addiction. 2004; 99: 109–116.
[24]
Athyros VG, Liberopoulos EN, Mikhailidis DP, Papageorgiou AA, Ganotakis ES, Tziomalos K, et al. Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort. Angiology. 2007; 58: 689–697.
[25]
Tanasescu M, Hu FB, Willett WC, Stampfer MJ, Rimm EB. Alcohol consumption and risk of coronary heart disease among men with type 2 diabetes mellitus. Journal of the American College of Cardiology. 2001; 38: 1836–1842.
[26]
Kitamura A, Iso H, Sankai T, Naito Y, Sato S, Kiyama M, et al. Alcohol intake and premature coronary heart disease in urban Japanese men. American Journal of Epidemiology. 1998; 147: 59–65.
[27]
Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991; 338: 464–468.
[28]
Solomon CG, Hu FB, Stampfer MJ, Colditz GA, Speizer FE, Rimm EB, et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation. 2000; 102: 494–499.
[29]
Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA, Jr, Stampfer MJ, Willett WC, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. The New England Journal of Medicine. 2003; 348: 109–118.
[30]
Beulens JWJ, Rimm EB, Ascherio A, Spiegelman D, Hendriks HFJ, Mukamal KJ. Alcohol consumption and risk for coronary heart disease among men with hypertension. Annals of Internal Medicine. 2007; 146: 10–19.
[31]
Bos S, Grobbee DE, Boer JMA, Verschuren WM, Beulens JWJ. Alcohol consumption and risk of cardiovascular disease among hypertensive women. European Journal of Cardiovascular Prevention and Rehabilitation. 2010; 17: 119–126.
[32]
Fernández-Jarne E, Martínez-Losa E, Serrano-Martínez M, Prado-Santamaría M, Brugarolas-Brufau C, Martínez-González MA. Type of alcoholic beverage and first acute myocardial infarction: a case-control study in a Mediterranean country. Clinical Cardiology. 2003; 26: 313–318.
[33]
Fuchs FD, Chambless LE, Folsom AR, Eigenbrodt ML, Duncan BB, Gilbert A, et al. Association between alcoholic beverage consumption and incidence of coronary heart disease in whites and blacks: the Atherosclerosis Risk in Communities Study. American Journal of Epidemiology. 2004; 160: 466–474.
[34]
Ebbert JO, Janney CA, Sellers TA, Folsom AR, Cerhan JR. The association of alcohol consumption with coronary heart disease mortality and cancer incidence varies by smoking history. Journal of General Internal Medicine. 2005; 20: 14–20.
[35]
Murray RP, Connett JE, Tyas SL, Bond R, Ekuma O, Silversides CK, et al. Alcohol volume, drinking pattern, and cardiovascular disease morbidity and mortality: is there a U-shaped function? American Journal of Epidemiology. 2002; 155: 242–248.
[36]
Song RJ, Nguyen XT, Quaden R, Ho YL, Justice AC, Gagnon DR, et al. Alcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program). American Journal of Cardiology. 2018; 121:1162–1168.
[37]
Mukamal KJ, Chung H, Jenny NS, Kuller LH, Longstreth WT, Jr, Mittleman MA, et al. Alcohol consumption and risk of coronary heart disease in older adults: the Cardiovascular Health Study. Journal of the American Geriatrics Society. 2006; 54: 30–37.
[38]
Ikehara S, Iso H, Yamagishi K, Yamamoto S, Inoue M, Tsugane S, et al. Alcohol consumption, social support, and risk of stroke and coronary heart disease among Japanese men: the JPHC Study. Alcoholism, Clinical and Experimental Research. 2009; 33: 1025–1032.
[39]
Marques-Vidal P, Montaye M, Arveiler D, Evans A, Bingham A, Ruidavets JB, et al. Alcohol consumption and cardiovascular disease: differential effects in France and Northern Ireland. The PRIME study. European Journal of Cardiovascular Prevention and Rehabilitation. 2004; 11: 336–343.
[40]
Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. British Medical Journal. 2011; 342: d636.
[41]
Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Meta-analysis of the relationship between alcohol consumption and coronary heart disease and mortality in type 2 diabetic patients. Diabetologia. 2006; 49: 648–652.
[42]
Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007; 115: 1285–1295.
[43]
Liu J, Tian Z, Gao B, Kunos G. Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells: differential involvement of adenosine. The Journal of Biological Chemistry. 2002; 277: 20927–20933.
[44]
Kleinhenz DJ, Sutliff RL, Polikandriotis JA, Walp ER, Dikalov SI, Guidot DM, et al. Chronic ethanol ingestion increases aortic endothelial nitric oxide synthase expression and nitric oxide production in the rat. Alcoholism, Clinical and Experimental Research. 2008; 32: 148–154.
[45]
Tirapelli CR, Leone AFC, Yogi A, Tostes RC, Lanchote VL, Uyemura SA, et al. Ethanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in rats. The Journal of Pharmacy and Pharmacology. 2008; 60: 331–341.
[46]
Maiorano G, Bartolomucci F, Contursi V, Minenna FS, Di Mise R, Palasciano A, et al. Noninvasive detection of vascular dysfunction in alcoholic patients. American Journal of Hypertension. 1999; 12: 137–144.
[47]
Hijmering ML, de Lange DW, Lorsheyd A, Kraaijenhagen RJ, van de Wiel A. Binge drinking causes endothelial dysfunction, which is not prevented by wine polyphenols: a small trial in healthy volunteers. The Netherlands Journal of Medicine. 2007; 65: 29–35.
[48]
Di Gennaro C, Biggi A, Barilli AL, Fasoli E, Carra N, Novarini A, et al. Endothelial dysfunction and cardiovascular risk profile in long-term withdrawing alcoholics. Journal of Hypertension. 2007; 25: 367–373.
[49]
Whitfield JB, Heath AC, Madden PAF, Pergadia ML, Montgomery GW, Martin NG. Metabolic and biochemical effects of low-to-moderate alcohol consumption. Alcoholism, Clinical and Experimental Research. 2013; 37: 575–586.
[50]
Xiao J, Huang JP, Xu GF, Chen DX, Wu GY, Zhang M, et al. Association of alcohol consumption and components of metabolic syndrome among people in rural China. Nutrition & Metabolism. 2015; 12: 5.
[51]
Budzyński J, Kłopocka M, Swiatkowski M, Pulkowski G, Ziółkowski M. Lipoprotein(a) in alcohol-dependent male patients during a six-month abstinence period. Alcohol and Alcoholism. 2003; 38: 157–162.
[52]
Mukamal KJ, Mackey RH, Kuller LH, Tracy RP, Kronmal RA, Mittleman MA, et al. Alcohol consumption and lipoprotein subclasses in older adults. The Journal of Clinical Endocrinology and Metabolism. 2007; 92: 2559–2566.
[53]
Tabara Y, Arai H, Hirao Y, Takahashi Y, Setoh K, Kawaguchi T, et al. The causal effects of alcohol on lipoprotein subfraction and triglyceride levels using a Mendelian randomization analysis: The Nagahama study. Atherosclerosis. 2017; 257: 22–28.
[54]
GBD 2019 Stroke Collaborators. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. Neurology. 2021; 20: 795–820.
[55]
Klatsky AL, Armstrong MA, Friedman GD, Sidney S. Alcohol drinking and risk of hemorrhagic stroke. Neuroepidemiology. 2002; 21: 115–122.
[56]
Hillbom M, Kaste M. Does alcohol intoxication precipitate aneurysmal subarachnoid haemorrhage? Journal of Neurology, Neurosurgery, and Psychiatry. 1981; 44: 523–526.
[57]
Hillbom M, Kaste M. Alcohol intoxication: a risk factor for primary subarachnoid hemorrhage. Neurology. 1982; 32: 706–711.
[58]
Donahue RP, Abbott RD, Reed DM, Yano K. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. The Journal of the American Medical Association. 1986; 255: 2311–2314.
[59]
Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. The New England Journal of Medicine. 1988; 319: 267–273.
[60]
Sacco RL, Elkind M, Boden-Albala B, Lin IF, Kargman DE, Hauser WA, et al. The protective effect of moderate alcohol consumption on ischemic stroke. The Journal of the American Medical Association. 1999; 281: 53–60.
[61]
Jimenez M, Chiuve SE, Glynn RJ, Stampfer MJ, Camargo CA, Jr, Willett WC, et al. Alcohol consumption and risk of stroke in women. Stroke. 2012; 43: 939–945.
[62]
Iso H, Baba S, Mannami T, Sasaki S, Okada K, Konishi M, et al. Alcohol consumption and risk of stroke among middle-aged men: the JPHC Study Cohort I. Stroke. 2004; 35: 1124–1129.
[63]
Larsson SC, Wallin A, Wolk A, Markus HS. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Medicine. 2016; 14: 178.
[64]
Patra J, Taylor B, Irving H, Roerecke M, Baliunas D, Mohapatra S, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types–a systematic review and meta-analysis. BMC Public Health. 2010; 10: 258.
[65]
Zhang X, Liu Y, Li S, Lichtenstein AH, Chen S, Na M, et al. Alcohol consumption and risk of cardiovascular disease, cancer and mortality: a prospective cohort study. Nutrition Journal. 2021; 20: 13.
[66]
Millwood IY, Walters RG, Mei XW, Guo Y, Yang L, Bian Z, et al. Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China. Lancet. 2019; 393: 1831–1842.
[67]
McCambridge J, Mitchell G, Lesch M, Filippou A, Golder S, Garry J, et al. The emperor has no clothes: a synthesis of findings from the Transformative Research on the Alcohol industry, Policy and Science research programme. Addiction. 2023; 118: 558–566.
[68]
McCambridge J, Mitchell G. The Views of Researchers on the Alcohol Industry’s Involvement in Science: Findings from an Interview Study. European Addiction Research. 2022; 28: 267–274.
[69]
Golder S, McCambridge J. Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of systematic reviews. Social Science & Medicine (1982). 2021; 289: 114450.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top